Rapport Therapeutics, Inc. Common StockRAPPNASDAQ
Loading
Cash on hand plus short-term liquid investments
3Y CAGR
+19.1%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
1.7x
Solid growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $52.65M | -7.3% |
| 2024 | $56.80M | -19.0% |
| 2023 | $70.17M | +125.2% |
| 2022 | $31.16M | - |